about
One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD.Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Arformoterol tartrate in the treatment of COPD.
@en
Arformoterol tartrate in the treatment of COPD.
@nl
type
label
Arformoterol tartrate in the treatment of COPD.
@en
Arformoterol tartrate in the treatment of COPD.
@nl
prefLabel
Arformoterol tartrate in the treatment of COPD.
@en
Arformoterol tartrate in the treatment of COPD.
@nl
P2860
P356
P1476
Arformoterol tartrate in the treatment of COPD.
@en
P2093
Maria G Matera
Mario Cazzola
P2860
P304
P356
10.1586/ERS.10.16
P577
2010-04-01T00:00:00Z